Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC

NCT03057106 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

301

Enrollment

NETWORK

Sponsor class

Conditions

Lung Cancer Metastatic

Interventions

DRUG: Durvalumab
DRUG: Tremelimumab
DRUG: Platinum-Based Drug

Sponsor

Canadian Cancer Trials Group

Collaborators

[object Object]
[object Object]
[object Object]